Real life efficacy and tolerability of cladribine: multicentre study in galicia (CLADRIGAL)

  1. Pato-Pato, A. 3
  2. Rodriguez-Regal, A. 6
  3. Alvarez, E. 7
  4. Garcia-Estevez, D. 8
  5. Costa-Arpin, E. 4
  6. Naveiro, J. 5
  7. Llaneza, M.
  8. Lopez-Real, A. 1
  9. Rodriguez, M. 2
  10. Aguado, M.
  11. Gonzalez, I. 7
  12. Lorenzo-Gonzalez, J. R. 3
  13. Prieto-Gonzalez, J. M. 5
  1. 1 Lucus Augusta Hosp, Neurol, Lugo, Spain
  2. 2 Cunqueiro Hosp, Vigo, Spain
  3. 3 Ribera Povisa Hosp, Neurol, Vigo, Spain
  4. 4 Santiago de Compostela Hosp, Neurol, Santiago De Compostela, Spain
  5. 5 Oviedo Hosp, Neurol, Oviedo, Spain
  6. 6 Pontevedra Hosp, Neurol, Pontevedra, Spain
  7. 7 Cunqueiro Hosp, Neurol, Vigo, Spain
  8. 8 Ourense Hosp, Neurol, Orense, Spain
Show affiliations +
Journal:
MULTIPLE SCLEROSIS JOURNAL

ISSN: 1352-4585,  1477-0970

Year of publication: 2022

Volume: 28

Issue: Supl. 3

Pages: 893-894

Type: Article

GOOGLE SCHOLAR lock_openOpen access editor

More publications in: MULTIPLE SCLEROSIS JOURNAL

Abstract

Meeting: 38th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis. Location: Amsterdam, NETHERLANDS. Date: OCT 26-28, 2022. Sponsor: European Comm Treatment & Res Multiple Sclerosis. Meeting Abstrac: tEP1134